Amid reports of the rising cost of EpiPens comes news of another drug that has increased in price. Insulin has gone up in price over the years and there have been diabetes patients who can't afford it.
A health body has called for tighter blood sugar guidelines in order to help those with diabetes manage the condition better as well as to improve the chances of detecting diabetes earlier. This applies to children and adults.
University of Texas Medical Branch at Galveston (UTMB) researchers found increased insulin levels in elderly test subjects, can restore the impaired muscle-building process responsible for age-related physical weakness.
Scientists at Washington University School of Medicine in St. Louis working with diabetic mice have examined in unprecedented detail the immune cells long thought to be responsible for type 1 diabetes.
A new study recently completed by a research team at the University of Central Florida may have found a way to produce an insulin capsule that can mean people with insulin-dependent diabetes will no longer need regular injections.
Ontario will spend $12 million this year and $30 million next year to provide 6,500 children suffering from insulin-dependent diabetes with access to the pumps, which monitor and regulate insulin levels.
Diabetics can now inhale their insulin rather than inject it. A powdered form of the medicine is delivered by a product called Exubera, which is on the market after receiving U.S. Food and Drug Administration approval earlier this year.